Antagonism of lipopolysaccharide-induced blood pressure attenuation and vascular contractility

作者：Ehrentraut S; Frede S; Stapel H; Mengden T; Grohe C; Fandrey J; Meyer R^*; Baumgarten G

来源：Arteriosclerosis, Thrombosis, and Vascular Biology, 2007, 27(10): 2170-2176.

DOI：10.1161/ATVBAHA.107.146100

• blood pressure
• sepsis
• toll-like receptor 4 antagonism
• vascular contractility

Objective-Aim was to assess whether lipopolysaccharide (LPS)-induced decrease of total peripheral resistance depends on Toll-like receptor (TLR)4 signaling and whether it is sensitive to NO-synthase or TLR4 antagonists. Methods and Results-C3H/HeN mice ( control), expressing a functional, and C3H/HeJ mice, expressing a nonfunctional TLR4, were compared. LPS ( 20 mg/kg) was injected i.p. 6 hours before hemodynamic measurements. L-NAME and SMT, inhibitors of NO production, and Eritoran, a TLR4 antagonist, were tested for their impact on vascular contractility. Aortic rings were incubated for 6 hours with or without LPS (1 mu g/mL), or with LPS + Eritoran ( 2 mu g/mL) and their phenylephrine-induced contractility was measured using a myograph. The expression of cytokines in aortic tissue was examined by real-time polymerase chain reaction. In control mice LPS induced a significant decrease of blood pressure and an increase of heart rate, whereas C3H/HeJ remained unaffected. LPS induced an increase of cytokine expression and a depression of vascular contractility only in control mice but not in C3H/HeJ. L-NAME and SMT increased contractility in all rings and restored LPS-dependent depression of contractility. Eritoran prevented LPS-induced loss of contractility.

• 出版日期2007-10